This is the first entry in my new ET series! It is a blog-like attempt at a morning roundup of ideas that may be " bongable " that day. When I am hiding from life and staying home I will update as much as possible. ~ stoney THE STORY: >>> The history of ZRAN recently has been unglorious Last Summer gap up on 4/24 saw a $22 close become a $26 open, the stk fails badly drifts down $22 becomes support, stk rallies to $26... then BIG selloff breaks support to $22 and then GAPS down the royal flush to $14. triple bottom here many retests up cycle to $18 where the stock BREAKS OUT to upside. Jeffries NEW price target is $24- the analyst making his first adjustment since a $14 PT.... THE OPINION: This may be a bongable call. THE STORY: >>> People are losing their minds. literally. thoughtlessness is a severe disease when you don't do it on purpose and many biotechs are tackling the problem of Alzheimers. One such company is TARGACEPT TRGT 5XVOL yesterday... stk went from $8.80 to $9.40 before giving most of it back. What's up? Well we know the company has 4 clinical and 3 pre clinical products in it's pipeline and that they specialize in central nervous system diseases. A mid stage study on TC-1734 for Alzheimers due out sometime soon... could that be it? Rumor, innuendo...$54 mil in cash not bad for a market cap of $170M. $1.4 mil debt though. THE OPINION: This may be a bongable call.